Westlake Chemical Partners CFO to Retire

Westlake Chemical Partners LP announced that M. Steven Bender plans to retire as Executive Vice President and Chief Financial Officer of its general partner and from the general partner’s Board of Directors.

Rhea-AI Filing Summary

Westlake Chemical Partners LP announced that M. Steven Bender plans to retire as Executive Vice President and Chief Financial Officer of its general partner and from the general partner’s Board of Directors. His retirement will be effective upon the appointment of his successor as chief financial officer.

The company states that Mr. Bender’s decision to retire was not the result of any disagreement with Westlake Chemical Partners GP LLC or Westlake Chemical Partners LP.

Insights

Corporate governance analyst

Planned CFO retirement with stated no‑disagreement language, neutral impact.

Westlake Chemical Partners LP reports that Executive Vice President and Chief Financial Officer M. Steven Bender intends to retire and also leave the Board of the general partner. The retirement becomes effective when a successor CFO is appointed, indicating a planned transition rather than an immediate vacancy.

The company explicitly notes that Mr. Bender’s decision was not the result of any disagreement with the general partner or the partnership. This language is commonly used to reassure investors that there are no disclosed disputes or governance conflicts tied to the leadership change.

Actual business impact will depend on the timing of appointing the new chief financial officer and how smoothly responsibilities transfer. Subsequent company communications may provide more detail on the incoming CFO’s background and any shifts in financial leadership priorities.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What executive leadership change did Westlake Chemical Partners (WLKP) disclose?

Westlake Chemical Partners disclosed that M. Steven Bender intends to retire as Executive Vice President and Chief Financial Officer of its general partner and also from the Board of Directors of the general partner, with his retirement effective upon the appointment of a successor chief financial officer.

Which roles is M. Steven Bender leaving at Westlake Chemical Partners (WLKP)?

M. Steven Bender is retiring from two key roles: Executive Vice President and Chief Financial Officer of Westlake Chemical Partners GP LLC, and member of the Board of Directors of the general partner, consolidating both his executive and board departures into a single planned transition event.

When will M. Steven Bender’s retirement at Westlake Chemical Partners (WLKP) take effect?

His retirement will take effect upon the appointment of his successor as chief financial officer. This means he will remain in his current role until the new CFO is formally appointed, supporting continuity in the partnership’s financial leadership during the transition period.

Was M. Steven Bender’s retirement due to a disagreement with Westlake Chemical Partners (WLKP)?

The company states that Mr. Bender’s decision to retire was not the result of any disagreement with Westlake Chemical Partners GP LLC or Westlake Chemical Partners LP, indicating no disclosed disputes regarding operations, policies, or practices tied to his decision to step down.

Which entity is the general partner of Westlake Chemical Partners (WLKP)?

Westlake Chemical Partners GP LLC is the general partner of Westlake Chemical Partners LP. It employs M. Steven Bender as Executive Vice President and Chief Financial Officer and oversees the Board of Directors from which he also plans to retire as part of this leadership transition.

How did Westlake Chemical Partners (WLKP) describe the nature of its CFO transition?

Westlake Chemical Partners described the change as a retirement by M. Steven Bender, effective upon the appointment of his successor as chief financial officer, and specifically noted that his decision to retire was not the result of any disagreement with the general partner or the partnership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:56 PM Learn about SEC filing dates

false 0001604665 0001604665 2026-02-18 2026-02-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 18, 2026

Westlake Chemical Partners LP

(Exact name of registrant as specified in its charter)

Delaware		001-36567		32-0436529
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

2801 Post Oak Boulevard, Suite 600 Houston, Texas		77056
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (713) 585-2900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common units representing limited partnership interests		WLKP		The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of CertainOfficers; Compensatory Arrangements of Certain Officers.

On February 18, 2026, M. Steven Bender notified Westlake Chemical Partners GP LLC (the “General Partner”), the general partner of Westlake Chemical Partners LP (the “Partnership”), of his intention to retire as Executive Vice President and Chief Financial Officer of the General Partner and from the Board of Directors of the General Partner, effective upon the appointment of his successor as chief financial officer. Mr. Bender’s decision to retire was not the result of any disagreement with the General Partner or the Partnership.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				WESTLAKE CHEMICAL PARTNERS LP
				By: Westlake Chemical Partners GP LLC
Date: February 23, 2026		By:		/s/ L. Benjamin Ederington
				Name:		L. Benjamin Ederington
				Title:		Executive Vice President, Legal and External
						Affairs and Director

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 2.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 17.6 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 11.0 KB